Drug Company

Dec 16, 2014 at 16:41 | Source: PTI
The company has launched Valganciclovir tablets, USP in the strength of 450 mg in the US market on December 15, 2014 and the product has been approved by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing to the BSE today.
Dec 15, 2014 at 16:57 | Source:
Combat Drugs has informed that a meeting of the Board of Directors of the Company will be held on December 22, 2014, to consider the resignation of the Director.
Dec 15, 2014 at 15:31 | Source: PTI
The company has received regulatory approval to launch its first New Chemical Entity (NCE) Synriam in seven African countries -- Nigeria, Uganda, Senegal, Cameroon, Guinea, Kenya and Ivory Coast, Ranbaxy Laboratories said in a statement.
Dec 10, 2014 at 22:00 | Source: CNBC-TV18
Karnataka's desire to be recognised as a manufacturing hub and not just an I-T destination may soon become reality. CNBC-TV18's Poornima Murali and Archana Shukla report that given the state's new incentives, pharma companies in Hyderabad are jumping ship and crossing the border.
Dec 10, 2014 at 13:24 | Source:
Meditab Holdings (Mauritius) a wholly owned subsidiary of the company, has entered into a definitive agreement to sell its entire 48.22 percent equity interest in Jiangsu Cdymax Pharmaceuticals Company, China to an affiliate of one of the other shareholders of Jiangsu, said the drug maker in its filing.
Dec 09, 2014 at 10:59 | Source: CNBC-TV18
In an interview to CNBC-TV18, Ashok Chawla, Chairperson, CCI, said the order on Sun-Ranbaxy merger is final and that the companies could be given additional 4 months in case the product divestment process exceeds 6 months.
Dec 09, 2014 at 08:38 | Source: PTI
As per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug due to "discoloration".
Dec 08, 2014 at 21:14 | Source: PTI
The nationwide recall has been initiated by the company on October 1 this year and has been initiated under Class-III which FDA defined as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".
Dec 02, 2014 at 08:34 | Source:
Sun Pharma Advanced Research Company announced that the US Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for Latanoprost BAK-free eyedrops.
Dec 01, 2014 at 20:21 | Source: PTI
The company had received approvals from the Bombay High Court earlier and today filed the order with the Registrar of Companies to conclude the merger process, Pfizer Ltd said in a statement.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st

News across the web »
Dec 02, 2014 at 04:12 | Source: Calcutta Telegraph News